Literature DB >> 6396008

Captopril-associated granulocytopenia in hypertension after renal transplantation.

K Shindo, F Matsuya, T Ura, A Jodai, H Shimomae, M Kuniyoshi, T Hirose, Y Kusaba, Y Saito.   

Abstract

A living related kidney transplant recipient with normal renal functioning and hypertension secondary to renal artery stenosis was treated with captopril and developed reversible granulocytopenia. Complications caused by captopril, an angiotensin converting enzyme inhibitor, have been reported previously in hypertensive patients with systemic lupus erythematosus or with renal artery stenosis after renal transplantation. It is recommended that this drug be used with caution in this setting.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6396008

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Captopril and systemic lupus erythematosus syndrome.

Authors:  C Sieber; E Grimm; F Follath
Journal:  BMJ       Date:  1990-09-29

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.